The induction of skin cancer involves both mutagenic and proliferative responses of the epidermis to ultraviolet (UV) light. It is believed that tumor initiation requires the mutagenic replication of damaged DNA by translesion synthesis (TLS) pathways. The mechanistic basis for the induction of proliferation, providing tumor promotion, is poorly understood. Here, we have investigated the role of TLS in the initiation and promotion of skin carcinogenesis, using a sensitive nucleotide excision repair-deficient mouse model that carries a hypomorphic allele of the error-prone TLS gene Rev1. Despite a defect in UV-induced mutagenesis, skin carcinogenesis was accelerated in these mice. This paradoxical phenotype was caused by the induction of inflammatory hyperplasia of the mutant skin that provides strong tumor promotion. The induction of hyperplasia was associated with mild and transient replicational stress of the UV-damaged genome, triggering DNA damage signaling and senescence. The concomitant expression of Interleukin-6 (IL-6) is in agreement with an executive role for IL-6 and possibly other cytokines in the autocrine induction of senescence and the paracrine induction of inflammatory hyperplasia. In conclusion, error-prone TLS suppresses tumor-promoting activities of UV light, thereby controlling skin carcinogenesis.
T umor initiation by mutagenic agents and tumor promotion by inflammatory agents are critical determinants of carcinogenesis. Ultraviolet light (UV) is considered a complete carcinogen, as it induces not only mutations but also a mild inflammatory and proliferative response of the skin, mediated by growth factors and inflammatory cytokines (1) (2) (3) .
Mutagenesis induced by DNA-damaging agents depends on specialized translesion synthesis (TLS) DNA polymerases that replicate damaged nucleotides, such as UV-induced photolesions, in an error-prone fashion. Thereby, TLS safeguards the perpetuation of replication on damaged templates at the expense of mutagenesis (4) . Rev1 is a key actor in error-prone TLS (5) . Although the protein can incorporate deoxycytosines opposite abasic nucleotides and some damaged guanines, Rev1 plays a regulatory, rather than a catalytic, role in error-prone TLS of other damages, including photolesions (5-7). The role of Rev1 in a particularly error-prone subpathway of TLS of photolesions is mediated by its N-terminal BRCT domain (6, 7) . In agreement, mouse embryonic stem cells with a disruption of this domain (Rev1 B/B cells) lack all UV-induced nucleotide transversion mutations and part of the transitions (8) . Nevertheless, this Rev1 allele is hypomorphic as in Rev1 B/B cells photolesions ultimately are replicated, in contrast to completely Rev1-deficient cells (7) . Rev1 B/B mice display no spontaneous phenotypes, unlike completely Rev1-deficient mice, supporting the hypomorphic nature of the Rev1 B allele, also at endogenous DNA damages (8, 9) .
Here, we have investigated the premise that tumor initiation by error-prone TLS of photolesions is a rate-limiting step in UV-induced skin cancer, using Rev1 B/B mice as a model. In addition to the hypomorphic Rev1 allele, the mice carried a defect in nucleotide excision repair (NER) of photolesions, predisposing them to skin cancer. Surprisingly, despite the defect in error-prone TLS, UV-induced skin carcinogenesis was further accelerated by the Rev1 B/B deficiency. We found that exposure of the skin of these mice to UV did induce severe inflammatory hyperplasia, providing strong tumor promotion. This result demonstrates that, paradoxically, error-prone TLS controls carcinogenesis by suppressing tumor-promoting activities of UV light, at the expense of the induction of mutations.
Results
Hypomorphic Rev1 Defect Accelerates Skin Carcinogenesis. We used NER-deficient (Xpc Ϫ/Ϫ ) hairless albino mice to investigate the effect of the Rev1 B/B allele on UV-induced skin carcinogenesis. In this sensitive model (i) UV dosimetry is not affected by melanin, and the absence of fur excludes shaving-induced artifacts (10); (ii) a very low, subtoxic, UV dose suffices to efficiently induce skin cancer with short latency (10, 11, reviewed in ref. 12); and (iii) the NER deficiency further increases the dependence on error-prone TLS of photolesions (7) . The Rev1 B/B mutation only slightly increased the UV sensitivity of the Xpc Ϫ/Ϫ skin as the minimal erythema/edema (toxic) dose (MED; 13) was reduced from 500 J/m 2 to 350 J/m 2 . To induce skin cancer, mice were exposed to a very low (40 J/m 2 ) daily UV dose and tumors were counted and measured weekly. Unexpectedly, squamous cell carcinomas (SCC) appeared significantly earlier in the Rev1-mutant mice than in the controls (Fig. 1) , although the total tumor load, growth, and histology were independent of the genotype. Genome Stability. Mutational inactivation of p53 precedes skin cancer (3, 11, 14) . The Rev1 defect resulted in only a slight reduction of the number of p53-mutant patches in premalignant skin (Table 1) in apparent contrast with the phenotype of cultured Rev1 B/B cells. To provide better evidence for a defect in error-prone TLS in vivo we determined the p53 mutation spectrum within SCC. In both genotypes C to T transitions predominated, typically at ''UV-fingerprint'' dipyrimidines (11, 15 ; Table 1 and Fig. S1 A and B) . Nevertheless, in Rev1-mutant SCC, the transitions at p53 were biased toward YCpG trinucleotides (Table 1 , Fig. S1 A and B), indicating mutagenesis by an alternative TLS pathway that specifically acts at YCpG sites. We investigated whether carcinogenesis in the Rev1 mutant was driven by increased genomic instability, caused by collapsed replication forks, rather than by nucleotide substitution mutagenesis. However, as we did not find an increase in the frequency of gross genomic alterations in Rev1-mutant SCC (Table 1 and Fig. S2 A and B) we conclude that carcinogenesis in the Rev1-mutant skin is initiated by Rev1-independent mutagenic TLS. To analyze responses of the Rev1-mutant epidermis to UV, we measured cell cycle progression in vivo. Thus, mice were irradiated with a single subtoxic UV dose. One hour before killing, replicating cells were pulse-labeled in vivo with Bromodeoxyuridine (BrdU) and epidermal cell suspensions were analyzed by bivariate flow cytometry (Fig. 2 A and B) . In both genotypes an S phase delay was induced early after UV exposure, evidenced by reduced BrdU incorporation per cell (population 3). At later time points, BrdU incorporation in many S-phase cells ceased completely (population 4), as shown before (16) . Populations 3 ϩ 4 were transiently enlarged in the Rev1-mutant epidermis indicating a slightly increased S phase delay. Strikingly, in the Rev1 mutant a population of very actively replicating cells emerged beyond 48 h after exposure (population 5). Such an excessive mitogenic response was also induced by the UV regimen of the carcinogenesis experiment since, after 8 days of very low-dose exposure, the Rev1-mutant skins displayed severe acanthosis (hyperplasia of the skin) and obvious signs of inflammation ( Fig. 2C and Figs. S3 and S4 ). We then investigated responses of skin patches to a single high UV dose, equitoxic for each genotype. As expected, initial levels of erythema and edema were very similar. However, after 3 weeks, in the Rev1-mutant mice the exposed patches were strongly elevated, erythematous and keratotic, resembling psoriatic plaques in humans (Fig. 2D ). In conclusion, uniquely in the Rev1-mutant skin, UV induces mitogenic activity followed by inflammatory acanthosis, and this phenotype is independent of the UV dose and toxicity.
IL-6 Expression, DNA Damage Signaling, and Senescence in the Rev1 B/B ;Xpc ؊/؊ Epidermis. Physiological and pathological acanthoses of the skin, such as psoriasis, are associated with expression of the inflammatory cytokine IL-6 (17). Indeed, immunohistochemical staining of UV-exposed mouse skin revealed high levels of IL-6 in all basal-layer keratinocytes in the Rev1-mutant mice, 24 h after a near-toxic UV dose (Fig. 3A) . It was recently hypothesized that the expression of IL-6 and other secreted factors, including IL-8, is induced by DNA damage signaling (18, 19) . To study whether UV-induced DNA damage signaling was increased in the Rev1-mutant epidermis, we stained skin sections for SQ/TQ peptides, phosphorylated by the DNA damage-signaling kinase Atr (20) , at 24 h after UV exposure. In the suprabasal layer of the epidermis both genotypes displayed comparable levels of SQ/TQ phosphorylation ( Fig. 3B) , presumably induced by stalled transcription complexes in these nonproliferating cells (21) . In contrast, in the proliferating basal layer of the epidermis, SQ/TQ phosphorylation was induced most significantly in the Rev1 mutant (Fig. 3B) .
In addition to inducing inflammation in a paracrine fashion, IL-6 and other cytokines also contribute to oncogene and genotoxin-induced senescence, in an autocrine fashion (18, 19, 22) . Indeed, in the Rev1-mutant epidermis the number of cells expressing the p53-dependent senescence marker Dec1 was increased by UV exposure (23, 24) (Fig. 3C) , with a concomitant reduction in the number of Ki-67-positive, proliferating, keratinocytes (Fig. 3D ). In addition, apoptosis was moderately increased in the Rev1 mutant (Fig. 3E ).
To study responses to chronic low-dose UV exposure, we irradiated mice for 8 days with the regimen of the carcinogenesis experiment. Under these conditions, increased DNA damage signaling at the basal layer of the acanthotic Rev1 B/B ;Xpc Ϫ/Ϫ epidermis ( Fig. 2E ) coincided in many cells with abundant Ki-67 staining (Fig. S4) . Surprisingly, apoptotic ( Fig. 2F ) and senescent cells (Fig. S4 ) were virtually absent from the basal layer. Furthermore, high levels of IL-6 and Amphiregulin, a growth factor associated with psoriasis-like inflammation (25) , were present throughout the acanthotic Rev1-mutant epidermis, although the morphological differences between the genotypes precluded quantification of the staining (Fig. S4) . Importantly, cyclobutane pyrimidine dimers (CPDs) were present in all Ki-67-positive basal layer keratinocytes (Fig. 2G) , indicating active proliferation of cells that carry mutagenic DNA damage. Taken together, these data indicate that in the Rev1 B/B epidermis increased DNA damage signaling initially induces senescence and apoptosis. At later stages, however, mitogenic signaling induces excessive proliferation of basal-layer keratinocytes that contain mutagenic DNA damage, and inhibitory consequences of DNA damage signaling are negated. The expression and secretion of IL-6, shortly after UV exposure and at later stages, is in agreement with a causal role in both the establishment of senescence and in the mitogenic signaling. Perturbation of Replication. We used mouse embryonic fibroblast (MEF) lines to study whether the enhanced DNA damage signaling in the Rev1 mutant is caused by stressed replication. Rev1 B/B ;Xpc Ϫ/Ϫ MEFs showed only slightly increased UV sensitivity (Fig. S5A) but phosphorylation of the Atr substrate Chk1 was markedly enhanced in the mutant (Fig. S5B) . Thus, the MEF lines react in a similar fashion to UV exposure as the epidermis.
We measured whether TLS of photolesions and the global progression of replication were affected by the Rev1 defect using the alkaline denaturation assay (Fig. 4A ) and a sensitive alkaline sucrose gradient-based assay (Fig. 4B) , respectively. Both assays revealed a delay of approximately 2 h in Rev1 B/B ;Xpc Ϫ/Ϫ MEFs (Fig. 4 C and D) . Therefore, the enhanced DNA damage responses in the Rev1 mutant are caused by a mild TLS defect and the consequent transient perturbation of replication. Given that replication is completed normally, albeit with some delay, the extent of the DNA damage signaling in the Rev1 B/B ;Xpc
MEFs and skin may be inappropriate.
Discussion
UV light induces nucleotide substitutions, as well as proliferation, required for the establishment of transformed clones (3). Tumor initiation and promotion determine the incidence and latency of carcinogenesis. Our data demonstrate that a defect in error-prone TLS, while probably leading to a reduction in skin cancer initiation, increases tumor promotion, which ultimately results in the acceleration of tumorigenesis. Of note, our mice carried a defect in NER that itself strongly accelerates skin carcinogenesis. It is of interest to investigate whether the Rev1 B allele accelerates skin carcinogenesis in NER-proficient mice, displaying long tumor latency. In contrast to the significantly reduced mutability of Rev1 B/B cells (8), UV-induced mutagenesis at p53 appears only marginally decreased in the Rev1 B/B ;Xpc Ϫ/Ϫ epidermis. However, because the hyperproliferation increases the number of mutable cells in the Rev1-mutant skin, the actual reduction in the mutation rate may be stronger than the apparent one. In Rev1-mutant SCC, the distribution of C to T transitions at p53 was shifted toward YCpG sites, presumably reflecting Rev1-independent mutagenic TLS. Spontaneous deamination converts 5-methylcytosines within YCpG-CPDs to thymidines that can be replicated by TLS polymerase , incorporating adenosines and resulting in C to T transitions (26, 27 ; pathway 1 in Fig. S6 ). Frequencies of gross genomic alterations were unaltered in the Rev1 B/B ;Xpc Ϫ/Ϫ mice indicating that skin carcinogenesis is not driven by genomic deletions, caused by collapsed replication forks. For these reasons, we hypothesize that poly- merase -dependent TLS initiates carcinogenesis in the Rev1-mutant skin.
In cultured Rev1 B/B ;Xpc Ϫ/Ϫ MEFs, replication of the UVdamaged genome was delayed only transiently, possibly owing to the activity of the compensatory TLS pathway. Nevertheless, UVinduced DNA damage signaling was enhanced in these cells and in the skin. In the epidermis, this was initially associated with increased levels of senescence and apoptosis, and with the expression of IL-6 throughout the basal layer of the Rev1 B/B ;Xpc Ϫ/Ϫ epidermis. At later stages after UV exposure, pronounced mitogenic stimulation in the Rev1-mutant skin was apparent, independent of the UV-dose, and levels of senescence and apoptosis were reduced. Indeed, it was shown that UV-induced mitogenic responses may quench a cell cycle arrest by inducing inhibitory phosphorylation of Chk1 (28) . The mitogenic stimulation in the Rev1 B/B ;Xpc Ϫ/Ϫ epidermis resulted in strong acanthosis that provided significant tumor promotion, a phenotype that is highly reminiscent of skin cancer promotion by the irritant 12-O-tetradecanoylphorbol 13-acetate following tumor initiation by 7,12-Dimethylbenzanthracene (2, 29).
It was found by others that IL-6 and other growth-and inflammatory factors are expressed in vitro and in vivo in response to both activated oncogenes and genotoxic agents, such as UV (18, 19, 22, 30, 31) , possibly in response to perturbed replication (18, 19) . IL-6 and related factors are involved in the establishment of senescence by an autocrine loop (22) . Independently, secreted IL-6 and other factors may mediate recovery of the skin (31) via the migratory stimulation of keratinocytes (32) and the induction of inflammation (1, 33) . However, IL-6 can also mediate the induction of inflammatory hyperplasia, which is associated with pathological phenotypes, including the stimulation of carcinogenesis (1, 17, 18, 30, 33, 34) . This indicates that normal recovery of the skin and the induction of pathological acanthosis are mechanistically similar.
In conclusion, based on published data and our data, we propose a model (Fig. 5) in which transient replicational stress in the absence of associated cytotoxicity, such as in the UVirradiated Rev1 B/B ;Xpc Ϫ/Ϫ epidermis, induces inappropriate DNA damage signaling. This results in the expression of IL-6 and probably other inflammatory and mitogenic factors. The associated induction of senescence may be partially dependent on IL-6 and other factors acting in an autocrine feedback loop. Additionally, secreted IL-6 and other factors trigger mitogenic activity, most likely via paracrine signaling. This results in the proliferation of photolesion-containing keratinocytes that, in combination with Rev1-independent mutagenic TLS, underlies the acceleration of skin tumorigenesis. Thus, a defect in errorprone TLS shifts the activity of UV light from a tumor initiator toward a tumor promoter.
Replicational stress-induced acanthosis may play a role in skin carcinogenesis in humans and mice defective for polymerase (35, 36) . It may also explain the finding that the additional disruption of error-prone TLS polymerase in polymerase -deficient mice further accelerates skin carcinogenesis (37, 38) . Apparently, in skin carcinogenesis, mutagenesis by error-prone TLS is the price to pay for preventing the tumor-promoting consequences of inappropriate DNA damage responses.
Materials and Methods
Generation of Rev1 B/B ;Xpc ؊/؊ Mice. Rev1 ϩ/B 129 Sv/Ola mice (8) were crossed with Xpc Ϫ/Ϫ mice (12) in the SKH albino hairless background for two generations and then intercrossed to obtain albino hairless Rev1 B/B ;Xpc Ϫ/Ϫ and littermate control Xpc Ϫ/Ϫ mice. Genotyping was performed as described (8, 13) . All required permissions for the mouse experiments were obtained.
Determination of the MED of UV and Skin Tumor Induction. Patches of the lateral-dorsal skin were exposed to a Hanovia Kromayer lamp, as described in ref. 13 . All exposures were given in duplicate on separate mice in two independent experiments. The mice were checked daily for erythema and/or edema and the MED was determined after 7 days.
To induce skin tumors, 11 Rev1 B/B ;Xpc Ϫ/Ϫ and 14 Xpc Ϫ/Ϫ mice (the ratios of males and females were similar in both groups) were placed in individual cages and chronically irradiated with a daily UV dose of 40 J/m 2 , using Philips TL-12/40W lamps, as described before (13) . This dose equals 0.08 ϫ MED for Xpc Ϫ/Ϫ mice. The dorsal skins were inspected weekly and the moment of appearance, number, size, morphology, and location of the tumors were recorded. When the largest tumors reached 4 mm in diameter, the animals were killed. The dissected tumors were split in two: one part was frozen in liquid nitrogen, while the other part was fixed in 4% buffered formaldehyde. Hematoxylin and eosin (H&E)-stained tumor sections were examined by an animal pathologist. The doses of all UV treatments by the Hanovia Kromayer lamp were normalized toward the dosimetry of the Philips lamp.
Comparative Genomic Hybridization. DNA was isolated from tumors and from untreated skin of the same mouse. Comparative genomic hybridization using a mouse BAC microarray containing 2,803 unique BAC clones from mouse genomic libraries at 1-Mb intervals was performed as described in ref. 39 .
Analysis of p53 Mutations. Seven Rev1 B/B ;Xpc Ϫ/Ϫ and 7 Xpc Ϫ/Ϫ mice were treated daily with 40 J/m 2 for 46 days. Then, epidermal sheets were isolated and immunostained for mutant p53 patches as described in ref. 40 .
To determine the p53 mutation spectrum, RNA was isolated from frozen SCC with the RNeasy mini kit (Qiagen) and reverse-transcribed. PCR of p53 cDNA was carried out as described in ref. 41 . PCR products were sequenced directly.
Cell Cycle Analysis ex Vivo. Rev1 B/B ;Xpc Ϫ/Ϫ (n ϭ 20) and Xpc Ϫ/Ϫ (n ϭ 20) mice were treated with 250 J/m 2 UV using Philips TL-12/40W lamps, or mocktreated. At each time point, four mice per genotype received an intraperitoneal injection of BrdU (5 mg in 300 L of PBS), 1 h before killing and dissection of the mid dorsal skin. An epidermal cell suspension was obtained and fixed in 70% ethanol. The DNA was stained for BrdU and with propidium iodide. DNA content and BrdU incorporation were analyzed using bivariate flow cytometry (FACSCalibur). Data analysis was performed on WinMDI software.
Histology and Immunohistochemistry.
For investigating responses to acute UV exposure, four Rev1 B/B ;Xpc Ϫ/Ϫ and four Xpc Ϫ/Ϫ mice were treated with 350 J/m 2 . Skin samples were collected 24 h after treatment. For chronic low-dose UV irradiation, six mice per genotype were exposed for 8 days to a daily dose of 40 J/m 2 . Mid dorsal UV-treated skins were dissected, snap-frozen, and embedded into Tissue-Tec blocks. Frozen 6-m sections were stained with H&E. To determine hyperplasia of the mouse skin, the thickness of the epidermis was measured in at least 10 microscopic frames per section per mouse. Reagents and conditions used for immunohistochemical staining are shown in Table S1 .
Generation and Analysis of MEF Lines. MEFs were isolated from 13.5-day-old embryos and immortalized with shRNA against p53 (42) .
UV-C exposure (Philips T.U.V. lamp, peak 254 nm) was performed on growing MEF lines, washed with PBS. At a similar dose, UV-C induces an approximately 100-fold higher frequency of photolesions compared with longer wavelength UV, used in the in vivo experiments. Measurement of TLS by alkaline denaturation, after treatment with 10 J/m 2 UV-C, was performed as described (Fig. 4A) (7) . Perturbation of replication in UV-exposed MEFs (5 J/m 2 ) was determined as described ( Fig. 4B) (7) .
Western Blot Analysis. Proteins were separated on 10% polyacrylamide-SDS gels followed by transfer to Hybond-P membranes (Amersham Biosciences). Antibodies are described in Table S1 . 
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